全部分类
  • 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaboran-2yl)aniline
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaboran-2yl)aniline的可视化放大

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaboran-2yl)aniline

A heterocyclic building block

此产品仅用于科学研究,我们不为任何个人用途提供产品和服务

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaboran-2yl)aniline的二维码
  • 库存: 现货
可选规格
  • 包装
    价格
    促销价
    数量
  • 1g
    ¥1012.00
    810.00
    - +
  • 5g
    ¥3287.00
    2630.00
    - +
  • 10g
    ¥125.00
    100.00
    - +
已选 0 0
金额: ¥0.00
首页 收藏
  • 货号: ajcx21362
  • CAS: 214360-73-3
  • 别名: 4-氨基苯硼酸频哪醇酯
  • 分子式: C12H18BNO2
  • 分子量: 219.1
  • 纯度: >98%
  • 溶解度: DMF: 20mg/mL,DMF:PBS (pH 7.2) (1:5): 0.16mg/mL,DMSO: 10mg/mL,Ethanol: 3mg/mL
  • 储存: Store at -20°C
  • 库存: 现货

Background

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaboran-2yl)aniline is a heterocyclic building block.1,2 It has been used in the synthesis of 3-aminoindazole-based multi-targeted receptor tyrosine kinase (RTK) inhibitors with anticancer activity and roscovitine derivatives that are dual inhibitors of cyclin-dependent kinases (CDKs) and casein kinase 1 (CK1).



1.Dai, Y., Hartandi, K., Ji, Z., et al.Discovery of N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-aminoindazole-based orally active multitargeted receptor tyrosine kinase inhibitorJ. Med. Chem.50(7)1584-1597(2007) 2.Paraiso, K.H.T., Haarberg, H.E., Wood, E., et al.The HSP90 inhibitor XL888 overcomes BRAF inhibitor resistance mediated through diverse mechanismsClin. Cancer Res.18(9)2502-2514(2012)

温馨提示 ×
商品已成功加入购物车!
购物车共 0 件商品
去购物车结算